Pharmacological correction of neurogenic lower urinary tract dysfunction in children

T.P. Borysova, T.V. Fedko, T.A. Nikolaenko, M.V. Boyko, O.A. Ostrovskaya, A.V. Obertinsky, K.V. Shevchenko


Background. The purpose was to evaluate the effectiveness and safety of pharmacological correction of neurogenic lower urinary tract dysfunction in children using noophen (phenibut) in combination with a prophylactic dose of furamag. Materials and methods. Twenty-four children aged 5 to 8 years with complaints of frequent urination in the daytime were under observation. All patients underwent neurological and uronephrological examination. The history of the disease, somatic status, general urine analysis and bacteriological culture of urine were evaluated. To assess the urodynamics of the lower urinary tract, a diary of urination, ultrasound examination of the kidneys and bladder, and uroflowmetry were studied. An assessment of the neuropsychiatric status was carried out, namely: symptoms of impaired attention, hyperactivity and impulsivity. For 28 days, children were prescribed standard urotherapy and noophen, a prophylactic dose of furamag, and group B vitamins. Results. After examination, a hyperactive bladder was diagnosed in 15 (62.5 %) and dysfunctional urination — in 9 (37.5 %) children. At the end of treatment, a positive dynamics in the clinical picture was observed in 21 (87 %) patients, of which 9 (38 %) fully recovered, and partial improvement was observed in 12 (49 %) children. The lack of effect from the therapy was observed in 3 (13 %) children. The change in the frequency of urination during therapy was characterized by a significant decrease in the first two weeks of treatment from 16.00 ± 1.35 to 11.10 ± 0.57 (p < 0.001). At the end of therapy, the frequency of urination was 8.90 ± 0.35 (p < 0.001). Urges to urinate were practically eliminated; urinary incontinence was not observed by the end of treatment course. After a course of treatment, the effective bladder volume increased by 38.9 % (p < 0.001). The positive impact on urodynamic indicators was shown: an increase in urination volume (by 35.1 %, p < 0.001), maximal (by 28.8 %, p < 0.002) and average urine flow rate (by 53.3 %, p < 0.001). During the observation, the examined children did not have a single case of urinary tract infection. We succeeded to prove the corrective effect of noophen drug on the symptoms of inattention and, to a greater extent, on hyperactivity-impulsivity; as well as the significance of the connection between the effectiveness of treatment for lower urinary tract dysfunction and neuropsychiatric positive dynamics (p < 0.004). A favorable safety profile of noophen and furamag preparations is shown. Conclusions. The therapeutic efficacy and safety of noophen in combination with the prophylactic dose of furamag for neurogenic lower urinary tract dysfunction in children was established, which was confirmed by a positive dynamics of clinical disease symptoms, urodynamic indicators, a decrease in the symptoms of inattention, hyperactivity and impulsivity.


neurogenic lower urinary tract dysfunction; children; treatment; noophen


Labutina NV, Kolbe OB, Sazonov AN, et al. Disorders of bladder emptying in children and adolescents - current approaches to diagnosis and treatment. Pediatria. 2007;86(6):29-35. (in Russian).

De Sousa A, Kapoor H, Jagtap J, Sen M. Prevalence and factors affecting enuresis amongst primary school children. Indian J Urol. 2007;23(4):354‐357. doi:10.4103/0970-1591.36703.

Athanasopoulos A, Gyftopoulos K, Giannitsas K, Fisfis J, Perimenis P, Barbalias G. Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study. J Urol. 2003;169(6):2253‐2256. doi:10.1097/01.ju.0000067541.73285.eb.

Morozov SL. Current concepts of neurogenic bladder dysfunction. Rossijskij vestnik perinatologii i pediatrii. 2013;58(4):24-29. (in Russian.).

Austin PF, Bauer SB, Bower W, et al. The standardization of terminology of lower urinary tract function in children and adolescents: Update report from the standardization committee of the International Children's Continence Society. Neurourol Urodyn. 2016;35(4):471‐481. doi:10.1002/nau.22751.

Morozov SL, Dlin VV. Cellular bioenergetics state in children with overactive bladder. The effectiveness of energotropic therapy. RMJ. 2016;24(18):1217-1222. (in Russian.).

Vishnevskiy EL. Overactive bladder syndrome in children. Voprosy sovremennoj pediatrii. 2007;6(2):63-70. (in Russian).

Bozhendayev TL, Guseva NB, Ignatyev RO, Nikitin SS. Dysfunctional urination as a marker of neurogenic bladder disorders in children. Pediatria. 2015;94(3):158-62. (in Russian).

Sinha S. Dysfunctional voiding: A review of the terminology, presentation, evaluation and management in children and adults. Indian J Urol. 2011;27(4):437‐447. doi:10.4103/0970-1591.91429.

Day-time lower urinary tract conditions. In: Radmayr C, Bogaert G, Dogan H.S, et al. Paediatric Urology: EAU Guidelines. Available from:

Zorkin SN, Gusarova TN, Borisova SA. Neurogenic bladder in children. Possibilities of pharmacotherapy. Lechaschii Vrach. 2009;(1):37-39. (in Russian).

Gel'dt VG, Ignat'ev RO, Nikitin SS, Guseva NB. The role of clinical and instrumental methods in diagnostics of overactive bladder in children. Russian Journal of Pediatric Surgery. 2014;18(3):24-29. (in Russian).

Bauer SB. Neurogenic bladder: etiology and assessment. Pediatr Nephrol. 2008;23(4):541‐551. doi:10.1007/s00467-008-0764-7.

Morozov SL, Dlin VV. The pattern of autonomic tone disorder and its correction in children with overactive bladder. Rossijskij vestnik perinatologii i pediatrii. 2014;59(6):74-78. (in Russian).

Otpuschennikova TV, Deryugina LA, Kazanskaya IV. Neurogenetic disorders of lower urinary tracts in children and their correction by transcranial therapy method. Lechaschii Vrach. 2016;(9):22-25. (in Russian).

Dlin VV, Morozov SL, Guseva NB, Shabelnikova EI. Pathogenetic substantiation of administering nootropics in children with overactive bladder. Effektivnaia farmakoterapiia. 2014;(16):6-10. (in Russian).

Maslova OI, Borisova SA, Artyukhina SV, Zorkin SN. The effect of derivatives of neurotransmitter amino acids on the urodynamic parameters of children with neurogenic bladder dysfunction. Lechaschii Vrach. 2011;(1):61-63. (in Russian).

Aleshin IV, Zaytsev YE. Efficacy of hopantenic acid in the combined treatment of patients with neurogenic bladder dysfunction. Meditsinskiy sovet. 2014;(1):58-61. (in Russian).

Von Gontard A, Baeyens D, Van Hoecke E, Warzak WJ, Bachmann C. Psychological and psychiatric issues in urinary and fecal incontinence. J Urol. 2011;185(4):1432‐1436. doi:10.1016/j.juro.2010.11.051.

Khaitovych MV. GABAB-ergic neuroprotection: clinical application. Liky Ukrai'ny. 2016;197-198:22-26. (in Ukranian).

Zavadenko NN, Suvorinova NIu. The results of the pharmacological treatment of attention deficit hyperactivity disorder: evaluation with neuropsychological methods. Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(9):19‐24. (in Russian).

Chutko LS, Surushkina EY, Yakovenko EA, Kropotov YD, Anisimova TI, Sergeev AV. Impulsivity in adolescents with attention deficit hyperactivity disorder. Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(11-2):13‐17. doi:10.17116/jnevro201611611213-17. (in Russian).

Nagorna NV, Dubova GV, Bordyugova YeV. Psychovegetative syndrome in children and possible ways to action. Tavricheskiy Mediko-Biologicheskiy Vestnik. 2013;16(3-1):100-115. (in Russian).

Maydannik VG, Mityuryaeva IO, Kukhta NM, et al. The use of "NOOFEN®100"preparation in the complex sanatorium and resort treatment of vegetative dysfunction affected by respiratory disease in children. Sovremennaya pediatriya. 2014;(63):72-9. doi:10.15574/SP.2014.63.72. (in Ukranian).

Voznyak AV. Effectiveness OF "Noofen®" in the complex treatment of vegetative dysfunction in children. Sovremennaya pediatriya. 2013;54(6):81-87. (in Ukranian).

Mityuryaeva I, Maydannik V, Demchuk S. Assessment of effectiveness and safety of the new integrated approach to treatment of various clinical forms of enuresis in children. Pediatrics. Eastern Europe. 2018;6(2):335-348. (in Russian).

Vishnevsky EL, Panin AP, Ignatyev RO. The efficiency of biofeedback treatment for overactive bladder in children. Rossijskij vestnik perinatologii i pediatrii. 2010;55(2):104-108. (in Russian).

Souvorinova NYu. Attention deficit disorder with hyperactivity in children and adolescents: possibilities of modern therapy. Consilium Medicum. Pediatria. 2018;(3):99-106. doi:10.26442/2413-8460_2018.3.99-106. (in Russian).

Ignatiev RO, Geldt VG, Guseva NB, Bozhedaev TL. Diagnostics of urinary disorders in children: is everyyhing done in a proper way? Rossijskij vestnik detskoj hirurgii, anesteziologii i reanimatologii. 2014;4(3):39-44. (in Russian).

Wenske S, Van Batavia JP, Combs AJ, Glassberg KI. Analysis of uroflow patterns in children with dysfunctional voiding. J Pediatr Urol. 2014;10(2):250‐254. doi:10.1016/j.jpurol.2013.10.010.

Copyright (c) 2020 CHILD`S HEALTH

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.


© Publishing House Zaslavsky, 1997-2020


   Seo анализ сайта